Centogene N.V. (CNTGF)
OTCMKTS
· Delayed Price · Currency is USD
0.1068
0.00 (0.00%)
At close: Dec 5, 2025
Centogene Revenue
In the year 2023, Centogene had annual revenue of 48.54M EUR with 2.24% growth. Centogene had revenue of 23.91M in the half year ending December 31, 2023, a decrease of -221.89%.
Revenue
48.54M EUR
Revenue Growth
+2.24%
P/S Ratio
0.06
Revenue / Employee
126.40K EUR
Employees
384
Market Cap
3.18M USD
Revenue Chart
* This company reports financials in EUR.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 122.89M |
| Glass House Brands | 196.17M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 937.00K |
| Silence Therapeutics | 25.83M |
| Global Cord Blood | 196.10M |
| Zomedica | 29.45M |